JP2527917B2 - 治療薬 - Google Patents

治療薬

Info

Publication number
JP2527917B2
JP2527917B2 JP5511397A JP51139793A JP2527917B2 JP 2527917 B2 JP2527917 B2 JP 2527917B2 JP 5511397 A JP5511397 A JP 5511397A JP 51139793 A JP51139793 A JP 51139793A JP 2527917 B2 JP2527917 B2 JP 2527917B2
Authority
JP
Japan
Prior art keywords
group
formula
alkyl group
compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP5511397A
Other languages
English (en)
Japanese (ja)
Other versions
JPH07502280A (ja
Inventor
ジョン アーミテッジ，バーナード
ガレス ボーウェン，ジョン
ジョン クロッスリー，マルコム
マイクル ハンニーボール，イアン
ウィリアム レスリー，ブルース
カー ミラー，トーマス
スポーウェッジ，マイクル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JPH07502280A publication Critical patent/JPH07502280A/ja
Application granted granted Critical
Publication of JP2527917B2 publication Critical patent/JP2527917B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP5511397A 1991-12-23 1992-12-12 治療薬 Expired - Fee Related JP2527917B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
GB9127252.6 1991-12-23
PCT/EP1992/002901 WO1993013097A1 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (2)

Publication Number Publication Date
JPH07502280A JPH07502280A (ja) 1995-03-09
JP2527917B2 true JP2527917B2 (ja) 1996-08-28

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5511397A Expired - Fee Related JP2527917B2 (ja) 1991-12-23 1992-12-12 治療薬

Country Status (22)

Country Link
US (1) US5464781A (enExample)
EP (1) EP0618916B1 (enExample)
JP (1) JP2527917B2 (enExample)
CN (1) CN1096784A (enExample)
AT (1) ATE171452T1 (enExample)
AU (1) AU656832B2 (enExample)
BG (1) BG98813A (enExample)
CA (1) CA2125858A1 (enExample)
CZ (1) CZ153594A3 (enExample)
DE (1) DE69227125T2 (enExample)
FI (1) FI943019A7 (enExample)
GB (1) GB9127252D0 (enExample)
HR (1) HRP921455A2 (enExample)
HU (1) HUT66971A (enExample)
IL (1) IL104169A0 (enExample)
IN (1) IN174405B (enExample)
MX (1) MX9207494A (enExample)
NO (1) NO942376L (enExample)
NZ (1) NZ246156A (enExample)
SI (1) SI9200408A (enExample)
SK (1) SK75094A3 (enExample)
WO (1) WO1993013097A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
WO1998013350A1 (en) 1996-09-25 1998-04-02 Zeneca Limited Qinoline derivatives inhibiting the effect of growth factors such as vegf
GB9800569D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
JP2003504363A (ja) 1999-07-09 2003-02-04 グラクソ グループ リミテッド プロテインチロシンキナーゼ阻害剤としてのアニリノキナゾリン類
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
AU779695B2 (en) 2000-04-07 2005-02-10 Astrazeneca Ab Quinazoline compounds
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
CN1984660B (zh) 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
KR100807920B1 (ko) 2003-12-23 2008-02-27 화이자 인코포레이티드 신규한 퀴놀린 유도체
EP1833482A4 (en) 2005-01-03 2011-02-16 Myriad Genetics Inc COMPOUNDS AND ITS THERAPEUTIC USE
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
EP2345652A1 (en) 2005-12-21 2011-07-20 Abbott Laboratories Antiviral compounds
RU2467007C2 (ru) 2005-12-21 2012-11-20 Эбботт Лэборетриз Производные [1,8]нафтиридина, полезные в качестве ингибиторов репликации вируса hcv
ES2395386T3 (es) * 2005-12-21 2013-02-12 Abbott Laboratories Compuestos antivirales
RU2441869C2 (ru) * 2005-12-21 2012-02-10 Эбботт Лэборетриз Противовирусные соединения
TWI392676B (zh) * 2005-12-21 2013-04-11 Abbott Lab 抗病毒化合物、其製備方法及用途
CA2672737A1 (en) 2006-12-20 2008-11-06 Abbott Laboratories Anti-viral compounds
KR20110025856A (ko) * 2008-07-03 2011-03-11 메르크 파텐트 게엠베하 오로라 키나아제 억제제로서 나프티리디니논
US8415333B2 (en) 2009-02-24 2013-04-09 Respiratorious Ab Bronchodilating diazaheteroaryls
WO2011063398A1 (en) * 2009-11-23 2011-05-26 Cylene Pharamaceuticals, Inc. Polymorphs and salts of a kinase inhibitor
NZ603332A (en) 2010-04-02 2014-11-28 Senomyx Inc Sweet flavor modifier

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
EP0222839A4 (en) * 1985-05-17 1988-11-09 Univ Australian ANTI-MALARIA COMPOUNDS.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc ｐ−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
EP0302303A3 (en) * 1987-07-22 1989-05-24 Schering Corporation Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
AU3158793A (en) 1993-07-28
HUT66971A (en) 1995-01-30
JPH07502280A (ja) 1995-03-09
NZ246156A (en) 1996-01-26
DE69227125T2 (de) 1999-02-18
FI943019A0 (fi) 1994-06-22
HRP921455A2 (en) 1994-12-31
SK75094A3 (en) 1995-04-12
NO942376D0 (enExample) 1994-06-22
FI943019A7 (fi) 1994-06-22
MX9207494A (es) 1993-07-01
ATE171452T1 (de) 1998-10-15
AU656832B2 (en) 1995-02-16
BG98813A (bg) 1995-05-31
HU9401877D0 (en) 1994-09-28
EP0618916B1 (en) 1998-09-23
CN1096784A (zh) 1994-12-28
IN174405B (enExample) 1994-11-26
WO1993013097A1 (en) 1993-07-08
EP0618916A1 (en) 1994-10-12
DE69227125D1 (de) 1998-10-29
NO942376L (no) 1994-06-22
GB9127252D0 (en) 1992-02-19
SI9200408A (en) 1993-09-30
CZ153594A3 (en) 1995-02-15
US5464781A (en) 1995-11-07
CA2125858A1 (en) 1993-07-08
IL104169A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
JP2527917B2 (ja) 治療薬
US5780482A (en) Condensed 4-aminopyridines with antirheumatic activity
Cao et al. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives
TW530048B (en) New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
CN101429198B (zh) 去氢骆驼蓬碱衍生物及其应用
CN100503607C (zh) 去氢骆驼蓬碱衍生物类化合物及其应用
RS59804A (sr) 2-(piridin-2-ilamino)-pirido(2,3-d)pirimidin-7-oni
JP6107650B2 (ja) テトラヒドロカルボリン誘導体
JPS60214787A (ja) ピラゾロピリジン誘導体．その製造方法及びその用途
TW200808722A (en) Novel compounds
JP2025531344A (ja) ２ｈ－ベンゾトリアゾール誘導体、その調製方法及びそれを含有する医薬組成物
JPS63258475A (ja) イミダゾピリジン誘導体
WO2025093059A1 (zh) 3-(氨基)亚甲基吲哚啉类衍生物及其制备方法和应用
CN111150731A (zh) 含氧吡格雷光学异构体或其盐的组合物及应用
WO2012129942A1 (zh) 手性3-羟基吡啶-4-酮类衍生物及其合成和用途
CN111166745A (zh) 含消旋氧吡格雷或其盐的组合物及应用
CN121057735A (zh) 一种氘代喜树碱化合物及其制备和应用
WO1995030676A1 (en) Antirheumatic 1-alkyl-4-hydroxy-3-(thien-3-yl) 1,8-naphthyridin-2(1h)-ones
ES2715348T3 (es) Compuestos que contienen anillos de nitrógeno fusionados para su uso como antagonistas de CRTH2
CN1160355C (zh) 嘌呤衍生物二水合物、含有该化合物作为有效成分的药物及其制备中间体
WO1995007909A1 (en) Alkyl-1-alkyl-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxylates as anti-rheumatic agents
JPH0428270B2 (enExample)
JPH06279446A (ja) 置換イミダゾピリダジン誘導体、その製造法、中間体および剤

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees